Dr. Sally Radovick

Dr. Scott M. Blackman is an associate professor of pediatrics at the Johns Hopkins University School of Medicine and attending at the Johns Hopkins Hospital. His areas of clinical expertise include pediatric endocrinology. Dr. Blackman cares for infants and children with all types of endocrinologic disorders, including diabetes mellitus and disorders of growth, puberty, and the thyroid and pituitary glands. He runs a multidisciplinary clinic for pediatric patients with cystic fibrosis-related diabetes (CFRD). He received his A.B. at Princeton University and his M.D. and Ph.D. degrees from the Vanderbilt University School of Medicine. He completed his internship and residency in pediatrics and fellowship in pediatric endocrinology at Johns Hopkins. Dr. Blackman has been a faculty member in pediatric endocrinology since completing his fellowship in 2007. Dr. Blackman’s research interests include identifying genetic variants responsible for endocrine abnormalities in CF including CF-related diabetes, which is seen commonly in teenagers and adults with cystic fibrosis. His long-term research goals include understanding molecular mechanisms of diabetes, such as type 1 and type 2 diabetes as well as CFRD. He is a recipient of the Gilead Research Scholars Award and has received awards from the Pediatric Endocrine Society and Cystic Fibrosis Foundation. He receives research funding from the NIH and CF Foundation. He serves as a mentor for EnVision, a national program to train endocrinologists in the care of people with CF; he serves on the Program Planning Committee for the North American CF Conference and on the editorial board of the Journal of Cystic Fibrosis. He serves on study sections for the NIH (NIDDK) and the Cystic Fibrosis Foundation. He is a member of the Society for Pediatric Research and is a U.S. News Top Doctor. Dr. Blackman is rated as an Experienced provider by MediFind in the treatment of Small for Gestational Age. His top areas of expertise are Exocrine Pancreatic Insufficiency, Type 2 Diabetes (T2D), Small for Gestational Age, and Type 1 Diabetes (T1D).

Melissa Oh is a Neonatologist and a Pediatrics provider in Baltimore, Maryland. Dr. Oh is rated as an Experienced provider by MediFind in the treatment of Small for Gestational Age. Her top areas of expertise are Patent Ductus Arteriosus, Small for Gestational Age, Polydactyly, and Hypoplasia of the Tibia with Polydactyly.

Dr. Garry R. Cutting is a Professor of Pediatrics and Medicine in the McKusick-Nathans Institute of Genetic Medicine of the Johns Hopkins University School of Medicine. He is the Aetna/U.S. Healthcare Professor of Medical Genetics at Johns Hopkins. Dr. Cutting received his undergraduate degree in biology and medical degree from the University of Connecticut. He completed residency training in pediatrics and a fellowship in medical genetics at the Johns Hopkins University School of Medicine. Dr. Cutting is the Medical Director of the DNA Diagnostic Laboratory of Johns Hopkins Genomics. He directed the Medical Genetics Residency Program at Hopkins from 1995 to 2004. Dr. Cutting is the recipient of the Paul di Sant’Agnese Distinguished Scientific Achievement Award from the Cystic Fibrosis Foundation and a MERIT award from the National Institutes of Health. He has published more than 160 peer-reviewed articles. Dr. Cutting was elected to the Society of Pediatric Research (1992), the American Society of Clinical Investigation (1995) and the Association of American Physicians (2017). Dr. Cutting’s primary interests lie in the interpretation of DNA variation and their effect upon human phenotypes. Dr. Cutting’s lab focuses on the effect of common and rare variants in the CFTR gene that cause the single gene disorder cystic fibrosis (CF). His lab operates the CFTR2 database, a resource composed of clinical and genetic data on almost 90,000 individuals with CF world-wide. His laboratory also studies the effect of clinically approved and novel modulators upon CFTR protein bearing disease-causing variants. Dr. Cutting’s laboratory is also leader in the identification and characterization of genetic modifiers of cystic fibrosis. His group is currently collaborating with teams at the University of North Carolina and the University of Washington, Seattle to identify common and rare modifier variants of disease severity by whole genome sequencing of 5200 individuals with CF. Dr. Cutting participates in the clinical translation of variant interpretation as the Medical Director of the DNA Diagnostic Laboratory at Johns Hopkins. Finally, as Editor of the journal Human Mutation Dr. Cutting oversees the review and publication of manuscripts reporting the mechanism, distribution and phenotype consequences of variation in our genomes. Dr. Cutting is rated as an Advanced provider by MediFind in the treatment of Small for Gestational Age. His top areas of expertise are Exocrine Pancreatic Insufficiency, Sjogren-Larsson Syndrome, Coffin-Siris Syndrome, and Meier-Gorlin Syndrome.